Stock Research for VRTX

VRTX

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

VRTX Stock Chart & Research Data

The VRTX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the VRTX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


VRTX Due diligence Resources & Stock Charts

The VRTX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View VRTX Detailed Price Forecast - CNN Money CNN View VRTX Detailed Summary - Google Finance
Yahoo View VRTX Detailed Summary - Yahoo! Finance Zacks View VRTX Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View VRTX Trends & Analysis - Trade-Ideas Barrons View VRTX Major Holders - Barrons
NASDAQ View VRTX Call Transcripts - NASDAQ Seeking View VRTX Breaking News & Analysis - Seeking Alpha
Spotlight View VRTX Annual Report - CompanySpotlight.com OTC Report View VRTX OTC Short Report - OTCShortReport.com
TradeKing View VRTX Fundamentals - TradeKing Charts View VRTX SEC Filings - Bar Chart
WSJ View Historical Prices for VRTX - The WSJ Morningstar View Performance/Total Return for VRTX - Morningstar
MarketWatch View the Analyst Estimates for VRTX - MarketWatch CNBC View the Earnings History for VRTX - CNBC
StockMarketWatch View the VRTX Earnings - StockMarketWatch MacroAxis View VRTX Buy or Sell Recommendations - MacroAxis
Bullish View the VRTX Bullish Patterns - American Bulls Short Pains View VRTX Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View VRTX Stock Mentions - StockTwits PennyStocks View VRTX Stock Mentions - PennyStockTweets
Twitter View VRTX Stock Mentions - Twitter Invest Hub View VRTX Investment Forum News - Investor Hub
Yahoo View VRTX Stock Mentions - Yahoo! Message Board Seeking Alpha View VRTX Stock Mentions - Seeking Alpha






Financial & Transaction Holdings

SECform4 View Insider Transactions for VRTX - SECform4.com Insider Cow View Insider Transactions for VRTX - Insider Cow
CNBC View VRTX Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for VRTX - OTC Markets
Yahoo View Insider Transactions for VRTX - Yahoo! Finance NASDAQ View Institutional Holdings for VRTX - NASDAQ


Stock Charts

FinViz View VRTX Stock Insight & Charts - FinViz.com StockCharts View VRTX Investment Charts - StockCharts.com
BarChart View VRTX Stock Overview & Charts - BarChart Trading View View VRTX User Generated Charts - Trading View


Latest Financial News for VRTX

Vertex to Announce Second Quarter 2018 Financial Results on July 25
Posted on Thursday July 12, 2018

Vertex Pharmaceuticals Incorporated (VRTX) will report its second quarter 2018 financial results on Wednesday, July 25, 2018 after the financial markets close. An archived webcast will be available on the company's website. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases.


What’s behind Gemphire Therapeutics’ Stock Price Rise
Posted on Monday July 09, 2018

On July 6, Gemphire Therapeutics (GEMP) stock closed at $8.09, ~70% higher than its 52-week low of $4.75 on May 7. After Gemphire announced positive clinical trial results on June 28, its stock price started to rise and closed at $5.24, and on June 29, it rose ~94.47% to $10.19.


Incyte’s Valuations on July 6
Posted on Monday July 09, 2018

According to Incyte Corporation (INCY), the firm is a “Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development, and commercialization of proprietary therapeutics.”


Why bluebird bio's Shares Have Tumbled 11.9% in 2018 So Far
Posted on Sunday July 08, 2018

The company's making progress, but competition could be fierce.


Enter a stock symbol to view the stock details.